Pain Management

Latest News


CME Content


The Committees voted 12 to 5 that the drug should be labeled as an abuse-deterrent product by the nasal route of abuse, but they voted 10 to 7 that the drug should not be labeled as an abuse-deterrent product by the intravenous route of abuse.

Ned Milenkovich, PharmD, JD, is chairman of the health care law practice at Much Shelist PC in Chicago, and former vice chairman of the Illinois State Board of Pharmacy. In this video, he discusses hemp regulation.

Ned Milenkovich, PharmD, JD, is chairman of the health care law practice at Much Shelist PC in Chicago, and former vice chairman of the Illinois State Board of Pharmacy. In this video, he discusses hemp, and why it is drawing increased attention from the pharmacuetical industry.